- Behavioral weight loss interventions: Do they work in primary care? Harvard Health
- Semaglutide 2.4 mg: Weight Loss in Real-world Study Matches STEP Trial Program Findings Patient Care Online
- Commercial Weight-Loss Program May Outperform DIY Approach Medscape
- Real-World Data Backs 2.4 mg Semaglutide (Wegovy) for Weight Management in Obesity Endocrinology Network
- View Full Coverage on Google News
Brought to you by Google News. Read the rest of the article here.